'We are using the 10% pullback from share price levels earlier in the month to get more aggressive on Hyatt,' the bank writes.

Walmart says Biggs stay on as CFO until a successor is named and will remain as an associate until he leaves in January 2023.

Bristol Myers shares fall after the FDA accepts its psoriasis-treating deucravacitinib drug application, and European regulators also validate its application.

Wedbush finds no shortage of in-store inventory for consumer electronics. And it says Roku products are in strong demand.

Twitter co-founder Jack Dorsey is set to step-down as CEO of the microblogging website, CNBC reported Monday.

'We do not recommend de-risking into weakness,' Chris Harvey, head of equity strategy for Wells, writes in a commentary.

Amazon has built more than 450 new facilities nationwide in recent months in order to beat supply chain issues.

Bitcoin 'is leading the market back from the depths of despair,' a cryptocurrency analyst says.

Stock futures rose Monday amid travel curbs tied to the omicron Covid variant.

Pfizer CEO Albert Bourla confirmed the drugmaker's plans to boost production of its Paxlovid antivrical treatment in the first against the spread of the new Omicron variant.